Thus, the aim of our study was to investigate the potential neuroprotective benefits of FGF10 in AD using both in vivo and in vitro approaches, and elucidate the mechanisms by which FGF10 may suppress tau hyperphosphorylation and prevent neuronal apoptosis. The gene discussed is MAPT; the disease is Alzheimer disease.